Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · IEX Real-Time Price · USD
17.49
+0.91 (5.49%)
At close: Jul 26, 2024, 4:00 PM
17.04
-0.45 (-2.57%)
After-hours: Jul 26, 2024, 5:42 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $353.83 million as of July 26, 2024. Its market cap has increased by 102.30% in one year.
Market Cap
353.83M
Enterprise Value
260.87M
1-Year Change
102.30%
Ranking
Category
Stock Price
$17.49
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $353.83M, an increase of 49.42%. That is a compound annual growth rate of 5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 295.10M | 175.79% |
| Dec 29, 2023 | 107.00M | -38.11% |
| Dec 30, 2022 | 172.90M | -54.54% |
| Dec 31, 2021 | 380.30M | 16.19% |
| Dec 31, 2020 | 327.30M | 185.35% |
| Dec 31, 2019 | 114.70M | 92.13% |
| Dec 31, 2018 | 59.70M | -72.75% |
| Dec 29, 2017 | 219.10M | -29.78% |
| Dec 30, 2016 | 312.00M | 31.76% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 376.57M |
| Talkspace | 373.31M |
| ADC Therapeutics | 371.43M |
| Vanda Pharmaceuticals | 366.65M |
| AC Immune | 366.04M |
| Foghorn Therapeutics | 365.72M |
| Nevro | 361.04M |
| Solid Biosciences | 353.09M |